Agency Information Collection Activities: Proposed Collection; Public Comment Request; ACL Generic for Administration on Aging Formula Grant Programs OMB Control Number 0985-New, 71869-71871 [2023-22956]
Download as PDF
<![CDATA[
Federal Register / Vol. 88, No. 200 / Wednesday, October 18, 2023 / Notices
in PowerPoint presentation format, not
PDF. We will not play videos or
animations during the public meeting
sessions and request the speakers to
exclude these materials from their
PowerPoint presentation and instead
submit any relevant video or animation
materials along with the written
comments. We request the speakers to
ensure that the presentation does not
include any inappropriate content
before submission.
Every primary speaker must declare at
the beginning of their presentation at
the meeting, as well as in their written
summary, whether they have any
financial involvement with the
manufacturer of the item that is the
subject of the HCPCS application that
the primary speaker presented, or any
competitors of that manufacturer with
respect to the item. This includes any
payment, salary, remuneration, or
benefit provided to that speaker by the
applicant.
2. 5-Minute Speakers
Any individual related to the public
meeting agenda item, including but not
limited to, an employee, stakeholder,
competitor, insurer, public consumer,
etc., may register and speak as a 5minute speaker. The deadline for
registering to be a 5-minute speaker is
5 p.m., EST, Tuesday, November 14,
2023.
Every 5-minute speaker must declare
at the beginning of their presentation at
the meeting, as well as in their written
summary, whether they have any
financial involvement with the
manufacturer of the item that is the
subject of the HCPCS code application
or agenda item that the 5-minute
speaker presented, or any competitors of
that manufacturer with respect to the
item. This includes any payment, salary,
remuneration, or benefit provided to
that speaker by the applicant. We will
not accept any other written materials,
outside of the written comments, from
a 5-minute speaker.
ddrumheller on DSK120RN23PROD with NOTICES1
3. All Other Attendees
All individuals who plan to attend the
virtual public meetings to listen and do
not plan to speak, may access the virtual
public meeting using the Zoom link
posted on the HCPCS website at https://
www.cms.gov/Medicare/Coding/
MedHCPCSGenInfo after the speaker
registration closes on Tuesday,
November 14, 2023.
Individuals who require special
assistance must register and request
special assistance services by 5 p.m.
EST, Tuesday, November 14, 2023.
VerDate Sep<11>2014
18:01 Oct 17, 2023
Jkt 262001
IV. Written Comments
The primary and 5-minute speaker(s)
must email a brief, written summary
(one paragraph) of their comments and
conclusions. Written comments from
anyone, including the primary and 5minute speaker(s), will only be accepted
when emailed to: HCPCS@cms.hhs.gov
before 5 p.m., EST on the date of the
virtual public meeting at which the
HCPCS code application that is the
subject of the comments is discussed.
V. Additional Information
The HCPCS section of the CMS
website also includes details regarding
the public meeting process for new
revisions to the HCPCS code set,
including information on how to join
the meeting remotely, and guidelines for
an effective presentation. The HCPCS
section of the CMS website also
contains a document titled ‘‘Healthcare
Common Procedure Coding System
(HCPCS) Level II Coding Procedures,’’
which is a description of the HCPCS
coding process, including a detailed
explanation of the procedures CMS uses
to make HCPCS coding determinations.
When CMS refers to HCPCS code or
HCPCS coding application above, CMS
may also be referring to circumstances
when a HCPCS code has already been
issued, but a Medicare benefit category
and/or payment has not been
determined. CMS is working diligently
to address Medicare benefit category
and payment determinations for new
items and services that may be DME,
prosthetic devices, orthotics and
prosthetics, therapeutic shoes and
inserts, surgical dressings, or splints,
casts, and other devices used for
reductions of fractures and dislocations
under Medicare Part B. Please check the
CMS website listed above for the final
agenda.
VI. Collection of Information
Requirements
This document does not impose
information collection requirements,
that is, reporting, recordkeeping or
third-party disclosure requirements.
Consequently, there is no need for
review by the Office of Management and
Budget under the authority of the
Paperwork Reduction Act of 1995 (44
U.S.C. 3501 et seq.).
The Administrator of CMS, Chiquita
Brooks-LaSure, having reviewed and
approved this document, authorizes
Chyana Woodyard, who is the Federal
Register Liaison, to electronically sign
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
71869
this document for purposes of
publication in the Federal Register.
Chyana Woodyard,
Federal Register Liaison, Centers for Medicare
& Medicaid Services.
[FR Doc. 2023–22953 Filed 10–17–23; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Community Living
Agency Information Collection
Activities: Proposed Collection; Public
Comment Request; ACL Generic for
Administration on Aging Formula
Grant Programs OMB Control Number
0985–New
Administration for Community
Living, Department of Health and
Human Services.
ACTION: Notice.
AGENCY:
The Administration for
Community Living (ACL) is announcing
an opportunity for the public to
comment on the proposed collection of
information listed above. Under the
Paperwork Reduction Act of 1995
(PRA), Federal agencies are required to
publish a notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension of an existing collection of
information, and to allow 60 days for
public comment in response to the
notice. This new information collection
solicits comments on the information
collection requirements relating to the
ACL Generic for Administration on
Aging Formula Grant Programs.
DATES: Comments on the collection of
information must be submitted
electronically by 11:59 p.m. (EST) or
postmarked by December 18, 2023.
ADDRESSES: Submit electronic
comments on the collection of
information to: Adam Mosey,
Adam.Mosey@acl.hhs.gov. Submit
written comments on the collection of
information to Administration for
Community Living, 330 C Street SW,
Washington, DC 20201, Attention:
Adam Mosey.
FOR FURTHER INFORMATION CONTACT:
Adam Mosey (202) 795–7631 or
Adam.Mosey@acl.hhs.gov.
SUPPLEMENTARY INFORMATION: Under the
PRA (44 U.S.C. 3501–3520), Federal
agencies must obtain approval from the
Office of Management and Budget
(OMB) for each collection of
information they conduct or sponsor.
‘‘Collection of information’’ is defined
in 44 U.S.C. 3502(3) and 5 CFR
SUMMARY:
E:\FR\FM\18OCN1.SGM
18OCN1
ddrumheller on DSK120RN23PROD with NOTICES1
71870
Federal Register / Vol. 88, No. 200 / Wednesday, October 18, 2023 / Notices
1320.3(c) and includes agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
The PRA requires Federal agencies to
provide a 60-day notice in the Federal
Register concerning each proposed
collection of information, including
each proposed extension of an existing
collection of information, before
submitting the collection to OMB for
approval. To comply with this
requirement, ACL is publishing a notice
of the proposed collection of
information set forth in this document.
With respect to the following
collection of information, ACL invites
comments on our burden estimates or
any other aspect of this collection of
information, including:
(1) whether the proposed collection of
information is necessary for the proper
performance of ACL’s functions,
including whether the information will
have practical utility;
(2) the accuracy of ACL’s estimate of
the burden of the proposed collection of
information, including the validity of
the methodology and assumptions used
to determine burden estimates;
(3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and
(4) ways to minimize the burden of
the collection of information on
respondents, including using automated
collection techniques when appropriate,
and other forms of information
technology;
(5) ACL issued a Notice of Proposed
Rulemaking (NPRM) to modify the
implementing regulations of the Older
Americans Act of 1965 (‘‘the Act’’ or
OAA) to add a new subpart (Subpart D)
related to Adult Protective Services
(APS) RIN 0985–AA18. 0985–New is
referenced in 88 FR 62503 pages 62503–
62522 published on September 12,
2023. Comments associated with this
proposed Generic Information
Collection (Gen IC) should be submitted
separately to the above listed program
contact.
As a unit of the Administration for
Community Living, the Administration
on Aging (AoA) provides expertise on
program development, advocacy, and
initiatives for older Americans and their
caregivers and families. Working with
State agencies, local agencies, grantees,
and community providers, AoA directs
programs authorized by the OAA, Elder
Justice Act (EJA), and other legislation
that supports older adults. Through
these programs multi-year State Plans
and assurances, and other financial
forms are needed to provide approval
and oversight of grant recipients.
VerDate Sep<11>2014
18:01 Oct 17, 2023
Jkt 262001
ACL is seeking OMB approval to add
a new Gen IC to ACL’s Paperwork
inventory. This Gen IC will cover AoA
formula grant programs for State Plans
on Aging and assurances, State Plans on
Adult Protective Services and
assurances, and other financial forms
associated with Aging formula grant
management. Adding a Gen IC will
allow for the collection of data across
programmatic and financial
management of the Aging and APS
formula grants.
Statutory Background
In 1965, Congress originally passed
the Older Americans Act (OAA) in
response to concerns by policymakers
about a lack of community social
services for older adults. The original
legislation established authority for
grants to States for community planning
and social services, research and
development projects, and personnel
training in the field of aging. Changes to
the OAA were made through the
Supporting Older Americans Act of
2020 (Pub. L. 116–131). This legislation
reauthorized the OAA and its programs
from Federal fiscal year (FFY) 2020
through 2024. The OAA provides the
foundation for the National aging
Network, which includes the
Administration on Aging (AoA), State
Units on Aging (SUA), Area Agencies on
Aging (AAA), tribal organizations,
service providers, and volunteers. SUAs
are an integral part of the network
responsible for developing and
administering a multi-year State plan
that advocates for and aids older
residents, their families, their
caregivers, and, in many States, for
adults with disabilities.
The Elder Justice Act, passed in 2010,
is the first comprehensive legislation to
address the abuse, neglect, and
exploitation of older adults at the
Federal level. The law authorized a
variety of programs and initiatives to
better coordinate Federal responses to
elder abuse, promote elder justice
research and innovation, support Adult
Protective Services systems, and
provide additional protections for
residents of long-term care facilities.
The importance of these services at the
State-level and local-level is
demonstrated by the fact that States
significantly leverage OAA funds to
obtain other funding for these activities.
The Coronavirus Response and Relief
Supplemental Appropriations Act of
2021 and the American Rescue Plan Act
provided two years of Federal funding
($188 million in each year) to support,
for the first time, the nationwide APS
formula grant program authorized by the
Elder Justice Act of 2010. That funding
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
was used by States to expand or develop
a variety of capabilities that were
necessary to meet increased needs due
to the public health pandemic, and
ongoing funding is necessary to
maintain the improved reach and
effectiveness of APS systems beyond the
pandemic.
The FY 2023 Omnibus
Appropriations Bill provided, for the
first time, an annual appropriation of
$15 million to continue providing
Federal formula grants to State APS
programs. This will be the first time
State entities are required to develop
and submit State plans on Adult
Protective Services under Section 2042
of the Elder Justice Act, 42 U.S.C.
1397m–1(b). However, States have
developed spending plans for the
formula funding received to date,
consistent with 45 CFR 75.206(d), and
to update those every three to five years.
This new Gen IC is for programmatic
and financial management of the Aging
and APS formula grants. The purpose of
the State Plans and assurances is to
document and provide the opportunity
for public comment of achievements
and planned activities for the multi-year
plan period. A wide range of
constituents use or will use the State
Plans to coordinate, monitor, evaluate,
and improve Aging Network and APS
support services by using the State
Plans as a blueprint for service planning
and delivery.
Additionally, ACL leverages State
Plans to understand the numerous
services older adults use, and to utilize
the information for advocating for the
needs of older adults and those who use
APS and for requesting additional
funding. The purpose of the other
financial forms that are a part of this
Gen IC is to facilitate OAA formula
grant management.
Financial forms provide statutorily
required information regarding each
State’s contribution to programs to
ensure compliance with legislative
requirements, pertinent Federal
regulations, and other applicable
instructions and guidelines issued by
ACL. This information will be used for
Federal oversight of the Aging Programs.
Based on ACL’s extensive experience
working with APS systems and OAA
grantees on their State plans, ACL does
not anticipate a significantly greater
level of detail for the development of
State plans for APS.
Since a new Gen IC does not permit
the public to examine the details of each
individual collection, the ACL Generic
for Administration on Aging Formula
Grant Programs 0985–New Proposed
Gen IC Plan can be found on the ACL
website for review and comment at:
E:\FR\FM\18OCN1.SGM
18OCN1
71871
Federal Register / Vol. 88, No. 200 / Wednesday, October 18, 2023 / Notices
https://www.acl.gov/about-acl/publicinput.
In accordance with the PRA 44 U.S.C.
3506(c)(2)(A); 44 U.S.C. 3507(a)(1)(D)
ACL details the proposed Gen IC
pertaining to:
• the method of collection;
• the category (or categories) of
respondents;
• the estimated maximum number of
burden hours (per year) for the specific
information collections, and against
which burden will be charged for each
collection actually used;
• ACL’s plans for how it will use the
information collected; and
• ACL’s internal procedures to ensure
that the specific collections comply
with the PRA, applicable regulations,
and the terms of the generic clearance.
Estimated Program Burden: ACL
estimates the burden of this collection
of information as follows:
ESTIMATED ANNUALIZED BURDEN TABLE
Respondent/data collection activity
State
State
State
State
Number of
responses per
respondent
Average
burden hours
per response
Total burden
hours
Unit on Aging (SUA) ................
Entity for APS ..........................
Entity for APS ..........................
Unit on Aging (SUA) ................
State Plan on Aging .........................
State Plan on APS ...........................
Required Assurances for APS (4) ...
Financial Forms ................................
14.7
56
56
56
1
1
3
5
80
6
10
1
1,176
336
1,680
280
Total Estimated Burden .............
...........................................................
........................
........................
........................
3,472
Dated: October 12, 2023.
Alison Barkoff,
Senior official performing the duties of the
Administrator and the Assistant Secretary for
Aging.
[FR Doc. 2023–22956 Filed 10–17–23; 8:45 am]
BILLING CODE 4154–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2021–P–1323]
Determination That NAROPIN
(Ropivacaine Hydrochloride) Solution,
50 Milligrams/10 Milliliters and 75
Milligrams/10 Milliliters, Were Not
Withdrawn From Sale for Reasons of
Safety or Effectiveness
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA, Agency, or we)
has determined that Naropin
(ropivacaine hydrochloride) solution, 50
milligrams (mg)/10 milliliters (mL) and
75mg/10mL, were not withdrawn from
sale for reasons of safety or
effectiveness. This determination means
that FDA will not begin procedures to
withdraw approval of abbreviated new
drug applications (ANDAs) that refer to
these drug products, and it will allow
FDA to continue to approve ANDAs that
refer to these drug products as long as
they meet relevant legal and regulatory
requirements.
FOR FURTHER INFORMATION CONTACT:
Alexander Poonai, Center for Drug
Evaluation and Research, Food and
Drug Administration, 10903 New
SUMMARY:
ddrumheller on DSK120RN23PROD with NOTICES1
Number of
respondents
Form
VerDate Sep<11>2014
18:01 Oct 17, 2023
Jkt 262001
Hampshire Ave., Bldg. 51, Rm. 6213,
Silver Spring, MD 20993–0002, 301–
796–3600, Alexander.Poonai@
fda.hhs.gov.
Section
505(j) of the Federal Food, Drug, and
Cosmetic Act (FD&C Act) (21 U.S.C.
355(j)) allows the submission of an
ANDA to market a generic version of a
previously approved drug product. To
obtain approval, the ANDA applicant
must show, among other things, that the
generic drug product: (1) has the same
active ingredient(s), dosage form, route
of administration, strength, conditions
of use, and (with certain exceptions)
labeling as the listed drug, which is a
version of the drug that was previously
approved and (2) is bioequivalent to the
listed drug. ANDA applicants do not
have to repeat the extensive clinical
testing otherwise necessary to gain
approval of a new drug application
(NDA).
Section 505(j)(7) of the FD&C Act
requires FDA to publish a list of all
approved drugs. FDA publishes this list
as part of the ‘‘Approved Drug Products
With Therapeutic Equivalence
Evaluations,’’ which is known generally
as the ‘‘Orange Book.’’ Under FDA
regulations, drugs are removed from the
list if the Agency withdraws or
suspends approval of the drug’s NDA or
ANDA for reasons of safety or
effectiveness or if FDA determines that
the listed drug was withdrawn from sale
for reasons of safety or effectiveness (21
CFR 314.162).
A person may petition the Agency to
determine, or the Agency may
determine on its own initiative, whether
a listed drug was withdrawn from sale
for reasons of safety or effectiveness.
This determination may be made at any
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
time after the drug has been withdrawn
from sale, but must be made prior to
approving an ANDA that refers to the
listed drug (§ 314.161 (21 CFR 314.161)).
FDA may not approve an ANDA that
does not refer to a listed drug.
Naropin (ropivacaine hydrochloride)
solution, 50mg/10mL and 75mg/10mL,
are the subject of NDA 020533, held by
Fresenius Kabi USA LLC, and initially
approved on May 1, 1998. Naropin is
indicated for the production of local or
regional anesthesia for surgery and for
acute pain management.
Naropin (ropivacaine hydrochloride)
solution, 50mg/10mL and 75mg/10mL,
are currently listed in the ‘‘Discontinued
Drug Product List’’ section of the Orange
Book.
Lachman Consultant Services, Inc.,
submitted a citizen petition dated
December 15, 2021 (Docket No. FDA–
2021–P–1323), under 21 CFR 10.30,
requesting that the Agency determine
whether Naropin (ropivacaine
hydrochloride) solution, 50mg/10mL
and 75mg/10mL, were withdrawn from
sale for reasons of safety or
effectiveness.
After considering the citizen petition
and reviewing Agency records and
based on the information we have at this
time, FDA has determined under
§ 314.161 that Naropin (ropivacaine
hydrochloride) solution, 50mg/10mL
and 75mg/10mL, were not withdrawn
for reasons of safety or effectiveness.
The petitioner has identified no data or
other information suggesting that these
drug products were withdrawn for
reasons of safety or effectiveness. We
have carefully reviewed our files for
records concerning the withdrawal of
Naropin (ropivacaine hydrochloride)
solution, 50mg/10mL and 75mg/10mL,
from sale. We have also independently
E:\FR\FM\18OCN1.SGM
18OCN1
]]>Agencies
[Federal Register Volume 88, Number 200 (Wednesday, October 18, 2023)]
[Notices]
[Pages 71869-71871]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-22956]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Community Living
Agency Information Collection Activities: Proposed Collection;
Public Comment Request; ACL Generic for Administration on Aging Formula
Grant Programs OMB Control Number 0985-New
AGENCY: Administration for Community Living, Department of Health and
Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Administration for Community Living (ACL) is announcing an
opportunity for the public to comment on the proposed collection of
information listed above. Under the Paperwork Reduction Act of 1995
(PRA), Federal agencies are required to publish a notice in the Federal
Register concerning each proposed collection of information, including
each proposed extension of an existing collection of information, and
to allow 60 days for public comment in response to the notice. This new
information collection solicits comments on the information collection
requirements relating to the ACL Generic for Administration on Aging
Formula Grant Programs.
DATES: Comments on the collection of information must be submitted
electronically by 11:59 p.m. (EST) or postmarked by December 18, 2023.
ADDRESSES: Submit electronic comments on the collection of information
to: Adam Mosey, [email protected]. Submit written comments on the
collection of information to Administration for Community Living, 330 C
Street SW, Washington, DC 20201, Attention: Adam Mosey.
FOR FURTHER INFORMATION CONTACT: Adam Mosey (202) 795-7631 or
[email protected].
SUPPLEMENTARY INFORMATION: Under the PRA (44 U.S.C. 3501-3520), Federal
agencies must obtain approval from the Office of Management and Budget
(OMB) for each collection of information they conduct or sponsor.
``Collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR
[[Page 71870]]
1320.3(c) and includes agency requests or requirements that members of
the public submit reports, keep records, or provide information to a
third party. The PRA requires Federal agencies to provide a 60-day
notice in the Federal Register concerning each proposed collection of
information, including each proposed extension of an existing
collection of information, before submitting the collection to OMB for
approval. To comply with this requirement, ACL is publishing a notice
of the proposed collection of information set forth in this document.
With respect to the following collection of information, ACL
invites comments on our burden estimates or any other aspect of this
collection of information, including:
(1) whether the proposed collection of information is necessary for
the proper performance of ACL's functions, including whether the
information will have practical utility;
(2) the accuracy of ACL's estimate of the burden of the proposed
collection of information, including the validity of the methodology
and assumptions used to determine burden estimates;
(3) ways to enhance the quality, utility, and clarity of the
information to be collected; and
(4) ways to minimize the burden of the collection of information on
respondents, including using automated collection techniques when
appropriate, and other forms of information technology;
(5) ACL issued a Notice of Proposed Rulemaking (NPRM) to modify the
implementing regulations of the Older Americans Act of 1965 (``the
Act'' or OAA) to add a new subpart (Subpart D) related to Adult
Protective Services (APS) RIN 0985-AA18. 0985-New is referenced in 88
FR 62503 pages 62503-62522 published on September 12, 2023. Comments
associated with this proposed Generic Information Collection (Gen IC)
should be submitted separately to the above listed program contact.
As a unit of the Administration for Community Living, the
Administration on Aging (AoA) provides expertise on program
development, advocacy, and initiatives for older Americans and their
caregivers and families. Working with State agencies, local agencies,
grantees, and community providers, AoA directs programs authorized by
the OAA, Elder Justice Act (EJA), and other legislation that supports
older adults. Through these programs multi-year State Plans and
assurances, and other financial forms are needed to provide approval
and oversight of grant recipients.
ACL is seeking OMB approval to add a new Gen IC to ACL's Paperwork
inventory. This Gen IC will cover AoA formula grant programs for State
Plans on Aging and assurances, State Plans on Adult Protective Services
and assurances, and other financial forms associated with Aging formula
grant management. Adding a Gen IC will allow for the collection of data
across programmatic and financial management of the Aging and APS
formula grants.
Statutory Background
In 1965, Congress originally passed the Older Americans Act (OAA)
in response to concerns by policymakers about a lack of community
social services for older adults. The original legislation established
authority for grants to States for community planning and social
services, research and development projects, and personnel training in
the field of aging. Changes to the OAA were made through the Supporting
Older Americans Act of 2020 (Pub. L. 116-131). This legislation
reauthorized the OAA and its programs from Federal fiscal year (FFY)
2020 through 2024. The OAA provides the foundation for the National
aging Network, which includes the Administration on Aging (AoA), State
Units on Aging (SUA), Area Agencies on Aging (AAA), tribal
organizations, service providers, and volunteers. SUAs are an integral
part of the network responsible for developing and administering a
multi-year State plan that advocates for and aids older residents,
their families, their caregivers, and, in many States, for adults with
disabilities.
The Elder Justice Act, passed in 2010, is the first comprehensive
legislation to address the abuse, neglect, and exploitation of older
adults at the Federal level. The law authorized a variety of programs
and initiatives to better coordinate Federal responses to elder abuse,
promote elder justice research and innovation, support Adult Protective
Services systems, and provide additional protections for residents of
long-term care facilities. The importance of these services at the
State-level and local-level is demonstrated by the fact that States
significantly leverage OAA funds to obtain other funding for these
activities.
The Coronavirus Response and Relief Supplemental Appropriations Act
of 2021 and the American Rescue Plan Act provided two years of Federal
funding ($188 million in each year) to support, for the first time, the
nationwide APS formula grant program authorized by the Elder Justice
Act of 2010. That funding was used by States to expand or develop a
variety of capabilities that were necessary to meet increased needs due
to the public health pandemic, and ongoing funding is necessary to
maintain the improved reach and effectiveness of APS systems beyond the
pandemic.
The FY 2023 Omnibus Appropriations Bill provided, for the first
time, an annual appropriation of $15 million to continue providing
Federal formula grants to State APS programs. This will be the first
time State entities are required to develop and submit State plans on
Adult Protective Services under Section 2042 of the Elder Justice Act,
42 U.S.C. 1397m-1(b). However, States have developed spending plans for
the formula funding received to date, consistent with 45 CFR 75.206(d),
and to update those every three to five years.
This new Gen IC is for programmatic and financial management of the
Aging and APS formula grants. The purpose of the State Plans and
assurances is to document and provide the opportunity for public
comment of achievements and planned activities for the multi-year plan
period. A wide range of constituents use or will use the State Plans to
coordinate, monitor, evaluate, and improve Aging Network and APS
support services by using the State Plans as a blueprint for service
planning and delivery.
Additionally, ACL leverages State Plans to understand the numerous
services older adults use, and to utilize the information for
advocating for the needs of older adults and those who use APS and for
requesting additional funding. The purpose of the other financial forms
that are a part of this Gen IC is to facilitate OAA formula grant
management.
Financial forms provide statutorily required information regarding
each State's contribution to programs to ensure compliance with
legislative requirements, pertinent Federal regulations, and other
applicable instructions and guidelines issued by ACL. This information
will be used for Federal oversight of the Aging Programs. Based on
ACL's extensive experience working with APS systems and OAA grantees on
their State plans, ACL does not anticipate a significantly greater
level of detail for the development of State plans for APS.
Since a new Gen IC does not permit the public to examine the
details of each individual collection, the ACL Generic for
Administration on Aging Formula Grant Programs 0985-New Proposed Gen IC
Plan can be found on the ACL website for review and comment at:
[[Page 71871]]
https://www.acl.gov/about-acl/public-input.
In accordance with the PRA 44 U.S.C. 3506(c)(2)(A); 44 U.S.C.
3507(a)(1)(D) ACL details the proposed Gen IC pertaining to:
the method of collection;
the category (or categories) of respondents;
the estimated maximum number of burden hours (per year)
for the specific information collections, and against which burden will
be charged for each collection actually used;
ACL's plans for how it will use the information collected;
and
ACL's internal procedures to ensure that the specific
collections comply with the PRA, applicable regulations, and the terms
of the generic clearance.
Estimated Program Burden: ACL estimates the burden of this
collection of information as follows:
Estimated Annualized Burden Table
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Respondent/data collection Form Number of responses per hours per Total burden
activity respondents respondent response hours
----------------------------------------------------------------------------------------------------------------
State Unit on Aging (SUA)..... State Plan on 14.7 1 80 1,176
Aging.
State Entity for APS.......... State Plan on 56 1 6 336
APS.
State Entity for APS.......... Required 56 3 10 1,680
Assurances for
APS (4).
State Unit on Aging (SUA)..... Financial Forms. 56 5 1 280
---------------------------------------------------------------
Total Estimated Burden.... ................ .............. .............. .............. 3,472
----------------------------------------------------------------------------------------------------------------
Dated: October 12, 2023.
Alison Barkoff,
Senior official performing the duties of the Administrator and the
Assistant Secretary for Aging.
[FR Doc. 2023-22956 Filed 10-17-23; 8:45 am]
BILLING CODE 4154-01-P
